Managers / Q1 2021 · view latest →
Saltoro Capital, LP
CIK 0001552059 · 4809 COLE AVENUE, SUITE 260, DALLAS, TX, 75205 · 214.317.4592
Reported Value
$400M
Q1 2021
Positions
101
Filings on Record
19
2019–present window
Filed
May 14, 2021
original filing
Summary
Saltoro Capital, LP reported $400M in U.S.-listed holdings across 101 positions for Q1 2021.
Its largest position, GPRE, represents 7.8% of the portfolio.
Compared with Q4 2020, the fund opened 58 new positions and exited 69.
Portfolio Metrics
Turnover
+28.0%
vs prior filed quarter
Top-10 Concentration
+17.2%
share of reported value
Largest Position
+7.8%
Green Plains
New / Exited
58 / 69
positions this quarter
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Other · 70.8% · $283M
- Common Stock · 19.7% · $79M
- US DOMESTIC · 8.3% · $33M
- REIT · 0.6% · $3M
- ADR · 0.6% · $2M
- Other · 0.1% · $243,000
Quarter-over-Quarter Changes full breakdown →
vs Q4 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SUNNOVA ENERGY INTL INC. | NEW | +279.0K | 279.0K | +$11M | $11M |
| ARK ETF TR | NEW | +72.0K | 72.0K | +$9M | $9M |
| ADAPTIVE BIOTECHNOLOGIES COR | NEW | +180.0K | 180.0K | +$7M | $7M |
| INVITAE CORP | NEW | +172.9K | 172.9K | +$7M | $7M |
| GREEN PLAINS INC | NEW | +234.0K | 234.0K | +$6M | $6M |
| INVESCO EXCH TRADED FD TR II | NEW | +67.5K | 67.5K | +$6M | $6M |
| GREEN PLAINS INC | NEW | +195.7K | 195.7K | +$5M | $5M |
| AMAZON COM INC | NEW | +900 | 900 | +$3M | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2021
82 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | GPREGREEN PLAINS INC | COM · NOTE 4.125% 9/0 | 7.84% | $31M | 5.46M |
| 2 | NOVAQSUNNOVA ENERGY INTL INC.history → | COM | 2.43% | $10M | 238.1K |
| 3 | INVITAE CORP | COM | 1.65% | $7M | 172.9K |
| 4 | ADPTADAPTIVE BIOTECHNOLOGIES CORhistory → | COM | 1.60% | $6M | 159.1K |
| 5 | NEWPARK RES INC | NOTE 4.000%12/0 | 0.93% | $4M | 3.75M |
| 6 | NOVAVAX INC | NOTE 3.750% 2/0 | 0.63% | $3M | 1.50M |
| 7 | RETROPHIN INC | NOTE 2.500% 9/1 | 0.62% | $2M | 2.41M |
| 8 | AMTXAEMETIS INC | COM NEW | 0.55% | $2M | 90.0K |
| 9 | COLONY CAP INC NEW | CL A COM | 0.49% | $2M | 303.0K |
| 10 | GOLAR LNG LTD | NOTE 2.750% 2/1 | 0.49% | $2M | 2.00M |
| 11 | BALLYS CORPORATION | COM | 0.46% | $2M | 28.1K |
| 12 | WLLWHITING PETE CORP NEW | COM NEW | 0.45% | $2M | 51.3K |
| 13 | ENCORE CAP EUROPE FIN LTD | NOTE 4.500% 9/0 | 0.43% | $2M | 1.50M |
| 14 | R1 RCM INC | COM | 0.38% | $2M | 62.3K |
| 15 | OMEROS CORP | NOTE 6.250%11/1 | 0.38% | $2M | 1.25M |
| 16 | INTERCEPT PHARMACEUTICALS IN | NOTE 3.250% 7/0 | 0.37% | $1M | 1.80M |
| 17 | CHAMPIONX CORPORATION | COM | 0.36% | $1M | 65.7K |
| 18 | SESEA LTD | SPONSORD ADS | 0.35% | $1M | 6.3K |
| 19 | PDC ENERGY INC | NOTE 1.125% 9/1 | 0.34% | $1M | 1.35M |
| 20 | AHCOADAPTHEALTH CORP | COM CL A | 0.33% | $1M | 36.0K |
| 21 | RICKRCI HOSPITALITY HLDGS INC | COM | 0.33% | $1M | 20.7K |
| 22 | SGITEMPUR SEALY INTL INC | COM | 0.33% | $1M | 36.0K |
| 23 | CHENIERE ENERGY INC | NOTE 4.250% 3/1 | 0.31% | $1M | 1.51M |
| 24 | AVAYA HLDGS CORP | NOTE 2.250% 6/1 | 0.31% | $1M | 1.00M |
| 25 | LBEURL BRANDS INC | COM | 0.29% | $1M | 18.9K |
| 26 | EZCORP INC | NOTE 2.875% 7/0 | 0.29% | $1M | 1.25M |
| 27 | MARINUS PHARMACEUTICALS INC | COM NEW | 0.27% | $1M | 70.6K |
| 28 | ENCORE CAP GROUP INC | NOTE 3.250% 3/1 | 0.27% | $1M | 1.00M |
| 29 | ACORDA THERAPEUTICS INC | NOTE 6.000%12/0 | 0.27% | $1M | 1.50M |
| 30 | AEOAMERICAN EAGLE OUTFITTERS IN | COM | 0.26% | $1M | 36.0K |
| 31 | ARTIUS ACQUISITION INC | COM CL A | 0.26% | $1M | 103.5K |
| 32 | BLDRBUILDERS FIRSTSOURCE INC | COM | 0.26% | $1M | 22.5K |
| 33 | LIGAND PHARMACEUTICALS INC | NOTE 0.750% 5/1 | 0.23% | $938,000 | 900.0K |
| 34 | DMTKQDERMTECH INC | COM | 0.23% | $935,000 | 18.4K |
| 35 | BILIBILIBILI INC | SPONS ADS REP Z | 0.22% | $867,000 | 8.1K |
| 36 | NTRANATERA INC | COM | 0.21% | $855,000 | 8.4K |
| 37 | EXECHESAPEAKE ENERGY CORP | COM · *W EXP 03/01/202 | 0.21% | $853,000 | 23.1K |
| 38 | LIGHTSPEED POS INC | SUB VTG SHS | 0.21% | $848,000 | 13.5K |
| 39 | BSYBENTLEY SYS INC | COM CL B | 0.21% | $845,000 | 18.0K |
| 40 | GOSSAMER BIO INC | NOTE 5.000% 6/0 | 0.20% | $808,000 | 900.0K |
| 41 | MUMICRON TECHNOLOGY INC | COM | 0.20% | $794,000 | 9.0K |
| 42 | LPLALPL FINL HLDGS INC | COM | 0.19% | $768,000 | 5.4K |
| 43 | BIOSIG TECHNOLOGIES INC | COM NEW | 0.19% | $756,000 | 175.4K |
| 44 | TEAM INC | NOTE 5.000% 8/0 | 0.19% | $743,000 | 750.0K |
| 45 | SYNASYNAPTICS INC | COM | 0.18% | $731,000 | 5.4K |
| 46 | SCORPIO TANKERS INC | NOTE 3.000% 5/1 | 0.17% | $698,000 | 701.0K |
| 47 | SAILPOINT TECHNOLOGIES HLDGS | COM | 0.17% | $684,000 | 13.5K |
| 48 | PARATEK PHARMACEUTICALS INC | NOTE 4.750% 5/0 | 0.17% | $678,000 | 750.0K |
| 49 | MARVELL TECHNOLOGY GROUP LTD | ORD | 0.17% | $661,000 | 13.5K |
| 50 | REVANCE THERAPEUTICS INC | COM | 0.16% | $643,000 | 23.0K |
| 51 | RETAIL VALUE INC | COM | 0.16% | $630,000 | 33.7K |
| 52 | II-VI INC | COM | 0.15% | $615,000 | 9.0K |
| 53 | EVREVERCORE INC | CLASS A | 0.15% | $593,000 | 4.5K |
| 54 | OUTFRONT MEDIA INC | COM | 0.15% | $589,000 | 27.0K |
| 55 | VECOVEECO INSTRS INC DEL | COM | 0.14% | $560,000 | 27.0K |
| 56 | TWLOTWILIO INC | CL A | 0.13% | $521,000 | 1.5K |
| 57 | DLTRDOLLAR TREE INC | COM | 0.13% | $515,000 | 4.5K |
| 58 | TWO HBRS INVT CORP | NOTE 6.250% 1/1 | 0.13% | $513,000 | 500.0K |
| 59 | GHGUARDANT HEALTH INC | COM | 0.12% | $481,000 | 3.1K |
| 60 | EHCENCOMPASS HEALTH CORP | COM | 0.11% | $442,000 | 5.4K |
| 61 | STAR PEAK ENERGY TRANSITION | CL A | 0.11% | $439,000 | 16.5K |
| 62 | XERIS PHARMACEUTICALS INC | NOTE 5.000% 7/1 | 0.11% | $424,000 | 250.0K |
| 63 | NANOSTRING TECHNOLOGIES INC | COM | 0.09% | $353,000 | 5.4K |
| 64 | PCTPURECYCLE TECHNOLOGIES INC | COM | 0.09% | $344,000 | 13.5K |
| 65 | EVHEVOLENT HEALTH INC | CL A | 0.08% | $320,000 | 15.9K |
| 66 | SUNPOWER CORP | DBCV 0.875% 6/0 | 0.08% | $319,000 | 300.0K |
| 67 | PARPAR TECHNOLOGY CORP | COM | 0.08% | $300,000 | 4.6K |
| 68 | BBIOBRIDGEBIO PHARMA INC | COM | 0.06% | $226,000 | 3.7K |
| 69 | ASPIRA WOMENS HEALTH INC | COM | 0.05% | $213,000 | 31.5K |
| 70 | ARDXARDELYX INC | COM | 0.05% | $184,000 | 27.8K |
| 71 | XOPSPDR SER TR | S&P OILGAS EXP | 0.04% | $146,000 | 1.8K |
| 72 | VIRPAX PHARMACEUTICALS INC | COM | 0.03% | $127,000 | 27.0K |
| 73 | URBAN-GRO INC | COM NEW | 0.03% | $114,000 | 13.5K |
| 74 | 9 METERS BIOPHARMA INC | COM | 0.03% | $105,000 | 90.0K |
| 75 | NOGNORTHERN OIL AND GAS INC MN | COM | 0.02% | $66,000 | 5.5K |
| 76 | POEMA GLOBAL HOLDINGS CORP | UNIT 99/99/9999 | 0.01% | $50,000 | 5.0K |
| 77 | BEBLOOM ENERGY CORP | COM CL A | 0.01% | $27,000 | 1.0K |
| 78 | ECP ENVIRONMENTAL GW OPT COR | UNIT 03/01/2026 | 0.00% | $10,000 | 1.0K |
| 79 | SPARTAN ACQUISITION CORP III | UNIT 99/99/9999 | 0.00% | $10,000 | 1.0K |
| 80 | DECARBONIZATION PLUS ACQU II | UNIT 01/19/2026 | 0.00% | $9,000 | 900 |
| 81 | COWEN INC | CL A NEW | 0.00% | $5,000 | 131 |
| 82 | SDSANDRIDGE ENERGY INC | COM NEW | 0.00% | $2,000 | 417 |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2024 | $30,000 | 1 | Feb 18, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $135,750 | 2 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | Under review | 4 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $79M | 23 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $37M | 31 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $111M | 53 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $98M | 55 | Aug 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $161M | 49 | May 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $125M | 37 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $246M | 45 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $417M | 46 | Aug 17, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q1 2022 | $427M | 80 | May 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $537M | 74 | Feb 9, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2021 | $283M | 100 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $247M | 95 | Aug 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $400M | 101 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $202M | 112 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.